0001437749-23-027772.txt : 20231005 0001437749-23-027772.hdr.sgml : 20231005 20231005163025 ACCESSION NUMBER: 0001437749-23-027772 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231002 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231005 DATE AS OF CHANGE: 20231005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 231311716 BUSINESS ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 8-K 1 acrx20231004_8k.htm FORM 8-K acrx20231004_8k.htm
false 0001427925 0001427925 2023-10-02 2023-10-02
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 2, 2023
 
ACELRX PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
 
         
Delaware
  
001-35068
  
41-2193603
(State of incorporation)
  
(Commission File No.)
  
(IRS Employer Identification No.)
 
 
1850 Gateway Drive, Suite 175
San Mateo, CA 94404
(Address of principal executive offices and zip code)
 
Registrant’s telephone number, including area code: (650) 216-3500
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value
ACRX
The Nasdaq Global Market
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 4.01.  Change in Registrant’s Certifying Accountants
 
(a) Dismissal of Independent Registered Public Accounting Firm
 
On October 2, 2023, the Audit Committee of the Board of Directors (the “Audit Committee”) of AcelRx Pharmaceuticals, Inc. (the “Company”) approved the dismissal of WithumSmith+Brown, PC (“Withum”) as the Company’s independent registered public accounting firm, effective immediately. On October 2, 2023, Withum was informed of such dismissal.
 
Withum’s audit report on the Company’s financial statements for the fiscal year ended December 31, 2022, did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope, or accounting principles, except for the following: the report included an explanatory paragraph regarding substantial doubt about the Company’s ability to continue as a going concern as result of its recurring operating losses and negative operating cash flows. Withum’s audit report on the Company’s financial statements for the year ended December 31, 2021, did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope, or accounting principles.
 
During the fiscal years ended December 31, 2022 and 2021, and the subsequent interim period through October 2, 2023: (i) there were no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304) with Withum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Withum, would have caused Withum to make reference to the subject matter of such disagreements in connection with its reports on the financial statements for such periods and (ii) there were no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except for the disclosure of the following material weakness in the Company’s internal control over financial reporting which existed during the Company’s fiscal year ended December 31, 2022 and the subsequent interim period through March 31, 2023, as disclosed in Part II, Item 9A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and Part I, Item 4 of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, respectively: the review procedures related to the technical accounting review and analysis over earnings per share calculations were insufficient to prevent or detect errors in the calculation. The Company remediated the material weakness as of June 30, 2023.
 
The Company provided Withum with a copy of this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the “SEC”) and requested Withum to furnish a letter addressed to the SEC stating whether it agrees with the above statements. A copy of Withum’s letter dated October 5, 2023, is filed as Exhibit 16.1 to this Current Report on Form 8-K.
 
(b) Engagement of New Independent Registered Public Accounting Firm
 
On October 2, 2023, the Audit Committee approved the engagement of BPM LLP (“BPM”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, effective immediately.
 
During the Company’s two most recent fiscal years ended December 31, 2022 and December 31, 2021 and through the date of this Current Report on Form 8-K, neither the Company nor anyone acting on its behalf consulted with BPM regarding either: (i) the application of accounting principles to a specific transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that BPM concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a “disagreement” within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 or a “reportable event” within the meaning of Item 304(a)(1)(v) of Regulation S-K.
 
 
 
 
Item 8.01. Other Information
 
As a result of the change in the Company’s certifying accountant described in Item 4.01 above, the Company will no longer seek stockholder ratification of the appointment of Withum as its independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Proposal 2”), as set forth in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on August 28, 2023, for the Company’s Annual Meeting of Stockholders to be held on October 10, 2023 (the “Annual Meeting”). The Company has withdrawn Proposal 2 and it will not be considered or voted upon at the Annual Meeting. Furthermore, the Company does not intend to submit a new proposal for stockholder ratification with respect to the appointment of BPM as its independent registered public accounting firm for the fiscal year ending December 31, 2023. In conjunction with the Company’s 2024 Annual Meeting of Stockholders, the Company intends to submit a proposal requesting that stockholders ratify the appointment of BPM as its independent registered public accounting firm for the fiscal year ending December 31, 2024.
 
 
Item 9.01.  Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
  
Description
   
16.1
  
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
Date: October 5, 2023
ACELRX PHARMACEUTICALS, INC.
  
  
 
By:  
/s/ Raffi Asadorian
  
   
Raffi Asadorian
  
   
Chief Financial Officer
  
 
 
 EX-16.1 2 ex_576629.htm EXHIBIT 16.1 ex_576629.htm

Exhibit 16.1

 

October 5, 2023

 

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Ladies and Gentlemen:

 

We have read AcelRx Pharmaceuticals, Inc’s. statements included under Item 4.01 of its Form 8-K dated October 5, 2023. We agree with the statements concerning our Firm under Item 4.01, in which we were informed of our dismissal on October 2, 2023. We are not in a position to agree or disagree with other statements contained therein.

 

Very truly yours,

 

/s/ WithumSmith+Brown, PC

 

San Francisco, California

 
 EX-101.SCH 3 acrx-20231002.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 acrx-20231002_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 acrx-20231002_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 acrx-20231002_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Oct. 02, 2023
Document Information [Line Items]  
Entity, Registrant Name ACELRX PHARMACEUTICALS, INC.
Document, Type 8-K
Document, Period End Date Oct. 02, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-35068
Entity, Tax Identification Number 41-2193603
Entity, Address, Address Line One 1850 Gateway Drive, Suite 175
Entity, Address, City or Town San Mateo
Entity, Address, State or Province CA
Entity, Address, Postal Zip Code 94404
City Area Code 650
Local Phone Number 216-3500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol ACRX
Security Exchange Name NASDAQ
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001427925
XML 8 acrx20231004_8k_htm.xml IDEA: XBRL DOCUMENT 0001427925 2023-10-02 2023-10-02 false 0001427925 8-K 2023-10-02 ACELRX PHARMACEUTICALS, INC. DE 001-35068 41-2193603 1850 Gateway Drive, Suite 175 San Mateo CA 94404 650 216-3500 false false false false Common Stock ACRX NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ(-.)_#1EZA$VY8<1(86>Y4)8 M8TS<;_3\1C0>09:'[L#TA(XA+@W#"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1> M9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG547>EYIM[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E* M%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,) MKM\,<'AT_@%02P,$% @ RX-%5V60>9(9 0 SP, !, !;0V]N=&5N M=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2 MVS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\ MFK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9 MHS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM M0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I- M"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O& M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 " #+@T57!T%-8H$ M "Q $ @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 M Q0 ( ,N#15<*FR_#[0 "L" 1 " :\ !D;V-0 M97)PC$ 8 )PG 3 M " &UL4$L! A0#% @ MRX-%5]W^X@A1! JQ !@ ("!# @ 'AL+W=O&UL4$L! A0#% @ RX-%5Y>* MNQS $P( L ( !;P\ %]R96QS+RYR96QS4$L! A0# M% @ RX-%5SJJHN= 0 / ( \ ( !6! 'AL+W=O M7!E&UL4$L%!@ ) D /@( /03 $! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.acrx.com/20231002/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports acrx-20231002.xsd acrx-20231002_def.xml acrx-20231002_lab.xml acrx-20231002_pre.xml acrx20231004_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "acrx20231004_8k.htm": { "nsprefix": "acrx", "nsuri": "http://www.acrx.com/20231002", "dts": { "schema": { "local": [ "acrx-20231002.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "acrx-20231002_def.xml" ] }, "labelLink": { "local": [ "acrx-20231002_lab.xml" ] }, "presentationLink": { "local": [ "acrx-20231002_pre.xml" ] }, "inline": { "local": [ "acrx20231004_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.acrx.com/20231002/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "acrx20231004_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "acrx20231004_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.acrx.com/20231002/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001437749-23-027772-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-027772-xbrl.zip M4$L#!!0 ( ,N#15>E#B2#8P, &X- 1 86-R>"TR,#(S,3 P,BYX M$.NX[86B1ULAW7_/7?. M1YLMW=(^()[J^'Z_^_+YSCU[O\DS\D=:IXR>19X22 M)&9OV3@>GY#)=#R9GH[)S6=*D;YQZ=2)M@(#YA2J,70D8-WJ4=]/U)@TW8C\_7MT%W"\Z4_M4'3R:3"0O2!NI\ M85MD<,%),5J9/PPE(9@&^D1IUV,4+[AK/4Z]I?ZAD*Z? V*&8C01TSBAXR3: MR4WJNU[59DY9)6R-2-7O/0@ZS@M3:F\?^L&UL$-P2NS)BQ)=S:6U4$7[5-?2 M#D5NQ+H?CI(.E N[Z200-T;"Y &5Q/$X(MQ[JQ:EEY^,S2_EDI<99*_4OTN> MJ:62*91Y)G.I?0>P(_;7TGP<;7_;G(956 W'Q?$Q=UOW7T2[LM,U!YEM\6'7- MUH:YUL8''8TKO"B47AK\Q%DW;0;>-[DD8:9.N178+IZ?O*RPII#6*^EV9V90 ML+9R.8NPX]*FV_[,^&($LZ"!/#'0[9JA70%%9M=;]QHNWMU9Y""GF:Q2_"\# M2>7RT$" HK3"0_COHBFL/#0:H#@8PORP>)!Z!R*BX 4(T]"'24Y3(\JP@+(*)M[W\_M0_S@2F(DQP M&FXQ(2)$$LXCS#A,M$1WZ5/]WZB>_SAX4JSG"U!10MVD7*N)P?2:)!*,<4*>"]_;K&*JA,U&Q*P$B"W^X,MB;#X M:,BRW9!G$->F[#E, .?]JXL\&9M! _S?7=[A[:M50= 82,?7-6^8$+7K,GZ0 MC^LQ*9YD%V=TNQV9_LMHC-"80 &[,NCU&,JY"'TYM3([ED=P1TSO88K(9@R[ M*UQ$3H-PG+F1#&_(U&&S8R8#X)@E=S2YE3N#@5(ASNF:?((IS@1'5'Q#:1$U M$\PIL[XLFOF<\7PJ#]66VF,+*OBZQQ(]4:NGG/+^C E\6QR634"-]5T";T2O%.NW23AD&7;+[6#15J>!NPU./;DY2,?L:7^2-,BK\$O MG_V/?,#9,]Z\5AE):N#78#I@LF0B_^*Y<6F;P(Y8JH'KS/!$T+F!6V.\U93W;&$>G+%;;Z"OIL:7 Z M;B^N1Y?''N-R_7;\NGPJ=X3:,6$9)!U?\,5^:FS-IO/=O@EGJ?DED979%;*+ M,A'1Q46\=BG.4E%L=>S47&-0#%[DBZ)2_X-9O.2_J#I/U_8FHP)6XH[DYTS' MSV"J+D[6?6"]&W4>.RCL%$_HBA.SR*Y_F[1C>\1"3J.R<@S6BH6N9N5TE?LR M%K+>5U36"2Z.AK6(V:&ST52].L3"WK,15KU* MI,P>M%%5O](N0T(])&8_4*$;.5::.I>@6(P0^U$52]NJ/<3;5Y MF:YJO6%APMK(JU[!87!R;015K^*PL($/_,;P%VTR[,^/^_OJ0_V#5M[Y'U!+ M P04 " #+@T57^X^)[O<% !#/ %0 &%CGC40IB%$ MA(ZO&B]][Z9_V^DT4,H#&@4Q4'S5H-#X?/WC#Y<_>=Y73#$+.([0<($&DQF- M,+N#!*,>,![$R$/-,_\WOW76.D?MBU;[XE,+]1X\3QX>$_KOA?PS#%*,1!HT M55^O&A/.IQ>^__;V=CH?LO@4V%A G)W[J^C&,ESNC?CZ@,W@3WZV(1*34*92THN4O5C%\* *R'WG@(R M1LAOWBK,DS]YS99WWCR=IU%C+1R#&#_C$9*?+\\=(V/;EQ$^Q6-9IFXPQ+'( M6$%,&![ICXL9RQTFLVC++)J_RRQ^UJ'QQ51X(R7)-,8-_X-Y]C C$-W3(R>L MA[60>9\'C-O(?1?XJ-D/0%RUQ\U[%_*X&8NA"Q\YXQW(HV;\B(_LC&W 8V5[ M0)I\-\52N<4RIBNVEF$2KF 056S+(7L#%L\Y%AUH8Y2,(=Q)/UUUBA2'IV-X M]2-,5(>2&Y[<4)F++__<4T[X0C2T@- 5E4KUJF':G642RT8 ;/L,BR&\>%.I M4A+L2LMP"C,69BU2,,DVCJGWTF]<9USH>\;V]Z7_GDP^S1NV4BU@X9X\EA%^ M"*(73GG^'$8,D@*I8)\&V2D)"B7DD8K:%5=-G''>S$FJJ:LAHF)IMU!L5U?1 MH56-):/;"IM$@Q)J6*GS'82S!%/>H2-@B9J7B1$&=SA.=$4O$U[1 460MNVP MXD8;Y.B[I$>*WZTY2HD+555S99M!,(QQ.TNR>MI=HA& M**ON& CP D=L[C[0!1+"5>5/D&2KI=8YI6"?!%9KNEX=WHE9=4%QM7$'5CF' MY:[<&:V8+41($M=2>;V,4%H?*U[(9BC/>$Q2S@+*'X-$9X6BL(-6 'DH-RN! M$_3.BB1M#2L"@X105AN+)NC0$-@4F.HO?2[\=PLSRMGB%B*S)TH==9!%"I%= M.2:7Q E2:2!@:)D*DKG48*-RJL.!^(/LH$!TY4G!#W*\]?GD'WR M0F7=+'KG)HJ$O.GR0RZ(FT;?%,0>Y!D-GBN_+#G7&TC=P7BB=329(EFADE[V M?7(K-I_8 -[,]ZV-D1_QR#N:3UN4,CI\X;)IWL.T--=9Y8C\$K MR1Y?%Q;4$/X1CVQ!.C?*>M*ZRJ ^MYC4U5FF4#;[ONE!RH/X+S(M7/X4!7_$ M,SE YX[)V)&@KVN!4ZBKSBT%@EGQBAS0;A@.#.[0[:[HATT(VPY0O422N:^W M5BG8)X&=)Z6B-'%O M2\1#6%5'U6N@5C_6&IY$.*L([UAU$U*".'E5K_P0CG MF-Y"DLSHTQ:&%>QZEHLVZ5?DJ(\J]/R%VL(I<6Q8H0^Q"0DG-#Q@YAO M,!+$&A>8@RI:8!?(=OW?&=&*TFGQ"Z2#7"*)TTG6%6R2[&0SYFFAU8 MY];),OC?.,BLL]Y'>P2TTVUP.!.-;M%L#0>$:]^R,854[31;,+;=H4@0C%"S M]$:Q>R??S<"+TP88W)XK"#KRB-Z&LSQZ7G&A%ZO[%B4(%H:PT%F\8WB>8 MC87UOC)XXQ/18:8!71CO&!9&'W3+4(OHZI[ABAQE[&A)7\,MPV)AH:)B5OQR M(Z8=D9QZ?(F#L<8AVOT5/9'#L.V"-1F2;$Z+KM<*]HI@<2"X%80LB#MB0CG_ MALU#@"'NH(M_"\O59;^D18H7">(:+GB3C%!:GQTO;)Q$5VQ=O_]$LO]/%;_\ M!U!+ P04 " #+@T579!=%7VA.@4B:!K-=,%VN M\Y3"GYM.Q@_1)&JSEG^HZM^9J2@ =+( M"WW9"Y=2KKIQO-EL&ML9\(: !3;1O(F/Z/ 5Z6I/%4X!]_&^\(3]*+IS8W& MMCJ=3JQ+3]""E0&QT5;\]\-HDBQI1B*6*TT2Q:5@W4+?'(F$2"UD[1 "(T)= M14=8I&Y%K79TTVILBS0\"0>"TR&1RA^.9"\@T?1R2[F,)=-X+56O1L25%XK=7-R1W*XR; M@F4K3L/X-(85T (K:>@(;QS0BJR3\>QIT*VD&*=G6G*1O!BQZKHXQE-!D\9" M/,\).77$RH[P7FHKW3+@*%P%GBOQ/)B.Z('S? M7W_+BA(R!H0C/G>'YS+\^2RF9,9I";$ZZ/488B32(096F7PV<,=,I]A\!;/S M8L=,QA282._S] [G806E4IPC;OO0?J(+5D@@N?Q&LC)J53"GS(:XML)*@ Z= MB7J!#<0ZE[ ;B-1,U*J64]Z?&:??UMF,@I'D)<0IHRG9#E/UKI^S_:);0Z\& M[Y1K/TUQJ2L.!_7&:!EY5F"OP7& IX\P%1OS4F9$7H.?COY'&(-X9OOLJY*D M 7X-IF.!"0K_AZTJIW85V!%+]>#Z0(F!5UFQJWP%&^3C)7Y5&">O">*(T5_ M)*:' Y%EZ_SPHBA+!"IQCKA-!&<)D_AE]H!!#8SP$F)FD"-68Z!*!?QHU+GX M5.76\#B?ES[->O!U6 Z+8DWA55R-55P];9JL,%QPXBJ_Y(%W6& C:O!_YVAUYK P@+'\-2AM;;E\'>CSAJXE%@7(Y4 MV'[=6ZGQMN+#J(;9&;)2H>V7"A5FE)4<-W[(\6I?R4J<]SZ)8_*SK)2X]4D) M*^O,2I;??9*EUJFSDN0/#R4Q68-6@OSIH2"5-J25*AT/5:DP/>T2-$_R5;/C M:B>#)XEJM=5K)X4GV:J%O6RGAR?I:IVK;2>&)^FIK8EN)XHGF>KKW'H[:3S) M5JNW">RD\"1+K=BBL-/!D^2T?E_$3@ZOLE*+71@[Q\R3M+1B!\A.!T_R4HM= MI[,=A_A"$FSXQ\=3B?I1_^S%._\!4$L#!!0 ( ,N#15=1B7VT3!4 *IX M 3 86-R>#(P,C,Q,# T7SAK+FAT;>T]:7,B.;*?IR/>?]!C=F?M>%R% M\87=1- 8>]CVM4#'=+PO&Z)*@*:+*EJJ,K"_?C,EU86+-G;[[.F)F3&4CI3R MSE2J.)X$4Y6:;!YB&5,=-PZ==KUOZW MV$SWB 8 DES#,"+W(5QAUK<1C/)Q@T9#E-EL:4SG+9 1LRG6T_] *Q MS)_9-&8&B#5L(Y!IK(,5+N/V&B;C=G89H1#,L]>MP[1FAK"%/H-4N4>J98M[1P0((GW1(#0,_"- B\-O(D@.ES.7PJ2@ M,EFA^3_OCOFB@2MB(OK"'8=YY@OTNM1Z56]G$?302CJ(CX./!>)1%#U@\49K MRCP'_@M.73HN-$?4E>RXDIGBWG-V/*#6L@V3"NIV@32+CVQ9:%9!$NNU_":48%][X@ M^73F,B2B@9*=6#V0?BC,=V7.&V:+A#O)%I-6IG:8?.<./AEQ)HA:(LNUU^WN MQRP65@>K!>9#F &B?"?Y#EI,!"<@ 4U<7,D"'5Z+QB9MJ04[:SI'+0GH!%0E M@PM%IIA4&9Q5,MQ8 <:%O^_2#)R6C!61.$K$R*J!%*FO-U1PZ@7 )>!CN$<( MOT1=/O8:-J"&B:,I%6/N-5#L"LW??EW0ZI$&_)QPCX?-3Y?=0>>$] >M0:=_ M7!DV7V05_4[[4Z\[Z';ZI'5Y0CJ?V[^W+L\ZI'UU<='M][M7E]^YM.J#E_9' MJ_][]_)L<'59)"?E=IG4JKOUPTV6\X^5]?QCDP4]+E\]"W(_O7GB MVR&J8F6'<(Z#TD>-IZRZ?".X>SC+ "_W.I<#TNM<7_4&+\:YUV"/0QA! I_T MF8V1#J[%(&;8M':(+XBUN^5L$W]$@@G#;J'@ 8?%=,!?HMZ8D98=8+-UN%/_ MX2F'I@0WVV,S<,3(5O2=43 D3 :$W;[ D2G#0=F MG4*GB4.72YB:>7EB=*WL6$?;MT+SR@[\(1CH6I'@G+>%ZK63I59_(%D>X+SU MV)A+#/*#2VA1I&VU.^>]S^3Z]U;O CY_&G3;K?-^D70OV^5\+?7<_+?565"0 M-=P+\IR(]T"H)'+&;'2R' (.-P\D >D$%A3;ST[X@ Y=1H:^ '?I?:$*$0=S M71,/Q-_EC-K1]_LC;\Z=8 (?JW\W*RFY;!0T5&!A'@@^GI@G!1570?B%L4WS M.!#P';\Z$>0;)@)N4]?@?N@'@3\U0'8 1K+%P+G/V-V'#WU%8.&OPE@.XC21 M2WJ*AO1=[A!KMB"_5M4_1W>#4A,^GP:_GR+&S"1&&P&;"?\&Y2ZKB;4NZ7JV M+T#?JU1A'WNW=0:D[3M:M9P< [M[T1;5&N,$8R.<04!B4\E@?4QN>)').4JI4ZYRV 6$E%EBIFG7:K>P<_$?W(B![01==$_;82 MBQ36ZYB+/=S9J^YLAO9OJ)\55 7^[ 7QM*5$'PTS3RN$[2=CI->U^[8_G7(I M8<<$Q8Q<^N6_RM:[O3[I3&>NOP3W.\OW:]!@>/H=_-4^244Y3:_ /7_Y,. Y M]53+<023TOPYYQZSE(ZR#G:KY S$>4Z7Y$3P&U8D_9"#>%O[NZ\C&#C>+*Q< ML^,V?+P2 W_NZ?0:>"<7L%T_;V_%>Z9Y,H"44KP2U^ _<3R64NF/5AZ8[X%R M[8.7YOX_G\4NUV&]7JT_-+GT!#K"+!3-PTP )OB,NH0MF!T&P%WP�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